Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Peter Little

Professor Emeritus

University of Queensland

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Biochemistry Biochemistry professors in Australia

About

Peter Little is a Professor Emeritus at the University of Queensland in Australia. His research focuses on metabolic diseases, atherosclerosis, and endothelial dysfunction, with recent publications examining the effects of various compounds on cardiovascular health and weight management. His work includes studies on the molecular mechanisms of natural polyphenols and targeted therapies for vascular smooth muscle cells.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Ying Zhou

University of Melbourne

AUSTRALIA

View details

Zhong-Ping Feng

Full Professor (Tenured)

University of Toronto

CANADA

View details

John R. Speakman

1000 talents professor

University of Aberdeen

UNITED KINGDOM

View details

Danielle Kamato

Group Leader

Griffith University

AUSTRALIA

View details

Dongdong Wang

McMaster University

CANADA

View details

Stefan Offermanns

Professor

Goethe University Frankfurt

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Little

Research Interests

Explore related searches

About

Articles (12)

The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21

The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review

Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells

Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling

Glutamate Attenuates the Survival Property of IGFR through NR2B Containing N-Methyl-D-aspartate Receptors in Cortical Neurons

Lysophosphatidic acid receptor 5 transactivation of TGFBR1 stimulates the mRNA expression of proteoglycan synthesizing genes XYLT1 and CHST3

Artemisinin inhibits glycosaminoglycan chain synthesizing gene expression but not proliferation of human vascular smooth muscle cells

Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologies

Collaborators (6)

Ying Zhou

Zhong-Ping Feng

John R. Speakman

Danielle Kamato

Dongdong Wang

Stefan Offermanns

Make your next move.